GET DAILY SIGNALSWelltower (WELL) Stock Analysis: Recent Price Trends and Market Outlook
Current Market Snapshot
Welltower Inc., a leading healthcare REIT, has shown resilience amid fluctuating real estate markets. The stock has generally maintained upward momentum, driven by strong demand for senior housing and outpatient care facilities. Despite some recent volatility, WELL’s performance aligns with broader trends in healthcare infrastructure investment. Its steady dividend yield continues to appeal to income-focused investors, while a substantial market cap underscores its prominence in the sector. Technical indicators suggest a neutral outlook, with potential for recovery if macroeconomic pressures ease.
-
Welltower Inc. (WELL) has posted a strong year-to-date strong performance, supported by growing demand in senior housing and healthcare real estate.
-
Analyst sentiment is mixed: JPMorgan downgraded WELL to Neutral, while Jefferies and UBS raised their price targets, reflecting cautious optimism.
-
The stock pulled back roughly 9% over the past month amid broader volatility in the REIT sector.
-
Third-quarter results highlighted robust revenue growth and led to an upward revision of full-year guidance, demonstrating operational strength.
-
Upcoming earnings in February 2026 will provide insights into continued momentum from aging demographics and portfolio expansions.
AI Trading Spotlight: WELL
Tickeron offers the WELL - AI Trading Agent with Corridor TP/SL 2%, 60min, using a corridor-based strategy on a 60-minute timeframe with take-profit and stop-loss levels set at 2%. This AI agent identifies trading opportunities within defined price channels, focusing on short-term intraday and swing trades. Historical performance shows consistent execution with an emphasis on volatility-adjusted moves. Traders can explore Tickeron’s backtested results and live metrics to incorporate algorithmic strategies into WELL trading.
Recent Price Movements and Analyst Activity
Over the past month, WELL stock has experienced choppy trading, closing at $187.70 on December 24, 2025—a modest 0.45% daily gain but a 9% drop from its 52-week high of $209.05.
Analyst actions have contributed to sentiment shifts:
-
JPMorgan downgraded WELL to Neutral on December 18, citing valuation concerns after its 49% YTD rally, with a $205 price target.
-
RBC Capital reaffirmed a Buy rating, emphasizing the long-term demographic tailwinds in senior housing.
-
Jefferies increased its price target to $231 from $210 on December 15, highlighting WELL as a top 2026 real estate pick.
-
UBS raised its price target to $232 from $203 earlier in December, maintaining a Buy rating based on solid fundamentals.
Industry reports have also influenced trading: Zacks and Motley Fool highlighted WELL as a top REIT for investors focused on aging population trends, reinforcing confidence despite short-term pullbacks.
Operational Performance
Welltower’s third-quarter results, announced October 28, 2025, continued to support the stock:
-
Revenue growth of 30% year-over-year
-
Funds from operations (FFO) up 20.7%
-
Raised full-year guidance to $5.27 per share
SEC filings in late October included a $7.5 billion at-the-market offering for expansion capital, signaling long-term growth potential. Trading volumes averaged 3.41 million shares amid this environment, reflecting active market participation.
Factors to Watch Going Forward
Investors should monitor WELL’s upcoming earnings, expected between February 9–17, 2026. Key items include:
-
Fourth-quarter 2025 revenue and normalized FFO updates
-
Performance of senior housing and outpatient portfolios
-
Full-year results relative to the $5.27 guidance
-
Commentary on portfolio investments, with $23 billion deployed year-to-date
Additional catalysts include potential dividend updates and broader regulatory or macroeconomic developments affecting healthcare REITs. Analysts continue to weigh WELL’s operational strength against sector-wide risks, offering a cautiously positive outlook for 2026.
Disclaimers and Limitations
Contributor
WELL in upward trend: price rose above 50-day moving average on October 30, 2026
WELL moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where WELL's RSI Oscillator exited the oversold zone, 10 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for WELL just turned positive on October 30, 2026. Looking at past instances where WELL's MACD turned positive, the stock continued to rise in 29 of 42 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day moving average for WELL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +3.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in 225 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
WELL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 26 of 63 cases where WELL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 41%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 28 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Aroon Indicator for WELL entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.620) is normal, around the industry mean (3.105). WELL has a moderately high P/E Ratio (105.032) as compared to the industry average of (28.160). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). Dividend Yield (0.015) settles around the average of (0.048) among similar stocks. WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a real estate investment trust
Industry PublishingBooksMagazines
Advertisement